PREVIOUS TREAMTED

Clinical trials for PREVIOUS TREAMTED explained in plain language.

Never miss a new study

Get alerted when new PREVIOUS TREAMTED trials appear

Sign up with your email to follow new studies for PREVIOUS TREAMTED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for KRAS lung cancer: drug duo targets tumors

Disease control Not yet recruiting

This study tests two drugs, luvometinib and anlotinib, together in people with advanced KRAS-mutated non-small cell lung cancer that has worsened after prior treatment. The goal is to see if the combination can shrink tumors. About 48 adults aged 18-75 will take part. This is not…

Matched conditions: PREVIOUS TREAMTED

Phase: PHASE2 • Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. • Aim: Disease control

Last updated May 13, 2026 16:01 UTC

PREVIOUS TREAMTED

Get alerted when new PREVIOUS TREAMTED trials appear

New hope for KRAS lung cancer: drug duo targets tumors